Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3771499016 | Selegiline only product in oromucosal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3771500013 | Product containing only selegiline in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Selegiline only product in oromucosal dose form | est un(e) (attribut) | Selegiline-containing product in oromucosal dose form | true | Inferred relationship | Some | ||
Selegiline only product in oromucosal dose form | est un(e) (attribut) | Selegiline only product | true | Inferred relationship | Some | ||
Selegiline only product in oromucosal dose form | a une forme pharmaceutique (attribut) | forme oromuqueuse | true | Inferred relationship | Some | ||
Selegiline only product in oromucosal dose form | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
Selegiline only product in oromucosal dose form | a pour principe actif (attribut) | Selegiline (substance) | true | Inferred relationship | Some | 1 | |
Selegiline only product in oromucosal dose form | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (clinical drug) | est un(e) (attribut) | True | Selegiline only product in oromucosal dose form | Inferred relationship | Some |
This concept is not in any reference sets